Seppo Salminen

Scientific Opinion on health claims already evaluated (ID 215, 568, 674, 712, 1398, 1633, 1974, 4191, 4192, 4193, 4236, 4335, 4698, 4704) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to fructo-oligosaccharides (FOS) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 781) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDL-cholesterol concentrations (ID 4663), reduction of intestinal transit time (ID 4664) and reduction of inflammation (ID 1985) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J J ) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen The members of the Claims Sub-Working Group on Weight Management/Satiety/Glucose and Insulin Control/Physical Performance, Kees de Graaf, Joanne Harrold, Mette Hansen, Mette Kristensen, Anders Sjödin and Inge Tetens

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to partially hydrolysed guar gum (PHGG) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 788), changes in short chain fatty acid (SCFA) production and/or pH in the gastro-intestinal tract (ID 787, 813), changes in bowel function (ID 813, 853, 1902, 1903, 1904, 2929, 2930, 2931), and reduction of gastro-intestinal discomfort (ID 813, 1902, 1903, 1904, 2929, 2930, 2931) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the safety of a ‘fermented black bean extract (Touchi extract)’ as a Novel Food ingredient (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to almonds and maintenance of normal blood LDL cholesterol concentrations (ID 1131) and maintenance of normal erectile function (ID 2482) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to gamma linolenic acid (GLA) and maintenance of normal blood LDL cholesterol concentrations (ID 2661, 4452, 4453), maintenance of normal blood pressure (ID 2662), reduction of menstrual discomfort (ID 495, 640, 1773, 1775), contribution to normal cognitive function (ID 1770), maintenance of the barrier function of the skin (ID 499, 591, 639, 676, 1554, 2003, 2065), “function of the cell membrane” (ID 1769), maintenance of normal structure, elasticity and appearance of the skin (ID 2660, 4296), and “anti-inflammatory properties” (ID 4454) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to copper and reduction of tiredness and fatigue (ID 272), maintenance of the normal function of the nervous system (ID 1723), maintenance of the normal function of the immune system (ID 1725) and contribution to normal energy-yielding metabolism (ID 1729) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of a health claim related to alpha linolenic acid and contribution to brain and nerve tissue development pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Probiotics (2011)

Marcos Da Silva Magalhães, Celia Lucia Ferreira, Jorma Tommola, Seppo Salminen, Maria Carmen Collado, Pauliina de Anna, Rosangela Marchelli

(Kirjan tai muun kokoomateoksen osa (B2))

Ota yhteyttä

Linkit

Asiantuntijuusalueet

Opetus

Tutkimus

Julkaisut

Järjestä:

Scientific Opinion on health claims already evaluated (ID 215, 568, 674, 712, 1398, 1633, 1974, 4191, 4192, 4193, 4236, 4335, 4698, 4704) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of health claims related to fructo-oligosaccharides (FOS) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 781) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the safety of a ‘fermented black bean extract (Touchi extract)’ as a Novel Food ingredient (2011)

Scientific Opinion on the substantiation of health claims related to almonds and maintenance of normal blood LDL cholesterol concentrations (ID 1131) and maintenance of normal erectile function (ID 2482) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of a health claim related to alpha linolenic acid and contribution to brain and nerve tissue development pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

Probiotics (2011)